G-H-3 International, Inc. (Pink Sheets: GHTI) announced that Dr. Sidney Cohen and Dr. Keith S. Ditman conducted what might be considered the most extensive and intensive �open studies� research on G-H-3 in this country. Dr. Cohen was one of the most powerful medical figures in Washington, being former director of the Division of Narcotic Addiction and Drug Abuse at the National Institute of Mental Health, and a clinical professor of psychiatry at UCLA. The initial studies indicated that 85% of the patients in the study reported a prompt and dramatic improvement in feelings of depression, relief of insomnia, and general sense of well-being. The most striking result was that cholesterol levels were reduced in 88% of the patients. Additional results related to arthritis showed marked improvement and in some cases complete relief. Dr. Alfred Sapse of UCLA, a renowned ophthalmologist, worked on a grant with the U.S. Institutes of Health and did research on G-H-3 and Dr. Anna Aslan�s work among the elderly. He stated, �It was so amazing to see these old people given up to die being treated with G-H-3 and then being, well, entirely changed. They were now happy, eager to participate in life around them, able to work and mean something to themselves and others.� Their ailments were either gone or greatly regressed at least to the point where they didn�t bother these old people. These studies are documented in a book authored by Herbert Bailey, WILL IT KEEP YOU YOUNG LONGER? The book was a million-copy best-seller. Flo Ternes, President, CEO of G-H-3, states, �The year 2007 will be an exciting year for the Company as we bring the therapy to our Clinic in Las Vegas.� Safe Harbor Statement Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of the Company's products, the competitive environment within the industry, the ability of the Company to continue to expand its operations, the level of costs incurred in connection with the Company's expansion efforts, economic conditions in the industry and the financial strength of the Company's customers and suppliers. The Company does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.
GH3 (CE) (USOTC:GHTI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more GH3 (CE) Charts.
GH3 (CE) (USOTC:GHTI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more GH3 (CE) Charts.